Trial NCT02833766

View at ClinicalTrials.gov 
Org. Study IDs: SAKK 24/14

Last trial update was posted on 2021-09-29

MeSH Interventions

Doxorubicin

MeSH Conditions

Breast Neoplasms

Other Conditions

Breast Cancer

Stopping Reasons

the trial was prematurely terminated as per SAKK board decision from 14th of November 2020. The trial is to be terminated after primary endpoint is reached.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID